THP Noninferior To TCbHP For pCR In HER2+ Early Breast Cancer
THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy, improve tolerability, and streamline care delivery.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.